Dosage Changes Require Provider Approval
You cannot change your dosage on your own. All dose adjustments must be reviewed and approved by your licensed provider.
How GLP-1 Dosing Works
GLP-1 medications (Semaglutide, Tirzepatide) are prescribed with a gradual dose escalation to minimize side effects:
Typical Semaglutide Progression:
Weeks 1-4: 0.25 mg weekly (starting dose)
Weeks 5-8: 0.5 mg weekly
Weeks 9-12: 1.0 mg weekly
Weeks 13+: 1.7 mg to 2.4 mg weekly (maintenance doses)
Typical Tirzepatide Progression:
Weeks 1-4: 2.5 mg weekly (starting dose)
Weeks 5-8: 5 mg weekly
Weeks 9+: 7.5 mg to 15 mg weekly (maintenance doses)
Your provider may adjust this schedule based on your response and tolerance.
How to Request a Dose Change
Log in to your portal at my.goodgirlrx.com
Message your provider
Explain your request:
What change you're requesting (increase, decrease, pause)
Why you're requesting it (side effects, plateau, etc.)
How you've been tolerating your current dose
Wait for your provider's response — They will evaluate your request and approve, deny, or suggest an alternative
When Dose Increases Are Appropriate
Your provider may approve a dose increase if:
You've been on your current dose for the recommended minimum time
You're tolerating your current dose well (minimal side effects)
You haven't reached your weight loss goals yet
There's no medical reason to stay at the current dose
When Dose Decreases May Be Recommended
Your provider may recommend decreasing your dose if:
You're experiencing significant side effects
You've lost substantial weight and lower doses may now be effective
Medical factors suggest a lower dose is safer for you
Do NOT Change Your Dose Without Approval
Taking more than prescribed is dangerous and ineffective. Higher doses don't necessarily mean faster results — they increase side effect risk without proportional benefit.
Taking less than prescribed may reduce effectiveness. If you're struggling with side effects, talk to your provider about management strategies rather than skipping doses.